FMC Secures First Product Registration in Brazil for Sofera Fall
Werte in diesem Artikel
FMC Corporation FMC has received its first product registration in Brazil for Sofero Fall pheromone. It is the first in its lineup of distinctive pheromone products for row crops, offering growers sustainable pest control methods, managing resistance and boosting productivity. Sofero Fall pheromone targets fall armyworms (Spodoptera frugiperda).The successful registration of Sofero Fall in Brazil will bring high-performance, sustainable crop protection solutions to growers and help fight against fall armyworms. It is focused on prevention rather than treatment, as it uses an innovative mating disruption technique. Sofero is a sprayable formulation combined with synthetics, biologicals and precision technologies to improve operational efficiency.FMC is also awaiting registration of Sofero Frugi pheromone, which also targets fall armyworms, in Mexico and is anticipated in 2027. The company plans to extend its portfolio with sustainable pest management programs and strengthen its global reach.FMC stock has lost 36.1% over the past year compared with the 12.9% decline in the industry.Image Source: Zacks Investment ResearchFMC expects revenues for the first quarter to be in the range of $750 million to $800 million, a 16% decrease at the midpoint from the same period in 2024. Volume is likely to fall as customers in various countries continue to cut inventories, and retailers and growers make cautious purchases in an environment of low commodity prices. Adjusted EPS is projected to be in the range of 5 cents to 15 cents, representing a 72% fall at the midpoint against the first quarter of 2024 due to the reduction in adjusted EBITDA.FMC’s Zacks Rank and Key PicksFMC currently carries a Zacks Rank #3 (Hold).Some better-ranked stocks in the Basic Materials space are DRDGOLD Limited DRD, Idaho Strategic Resources, Inc. IDR and Carpenter Technology Corporation CRS. DRD, IDR and CRS have a Zacks Rank #2 (Buy) each at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.The Zacks Consensus Estimate for DRD’s current-year earnings is pegged at $1.06 per share, indicating a 29.3% year-over-year rise. Its shares have soared 80.5% in the past year.The Zacks Consensus Estimate for IDR’s 2025 earnings is pegged at 78 cents per share, indicating a rise of 16.4% from year-ago levels. IDR’s earnings beat the consensus estimate in three of the trailing four quarters while missing once, with the average surprise being roughly 77.5%.The Zacks Consensus Estimate for Carpenter Technology’s current fiscal-year earnings is pegged at $6.95 per share. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with the average surprise being 15.7%. CRS’ shares have soared 116.5% in the past year. Zacks Names #1 Semiconductor StockIt's only 1/9,000th the size of NVIDIA which skyrocketed more than +800% since we recommended it. NVIDIA is still strong, but our new top chip stock has much more room to boom.With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $803 billion by 2028.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Carpenter Technology Corporation (CRS): Free Stock Analysis Report FMC Corporation (FMC): Free Stock Analysis Report DRDGOLD Limited (DRD): Free Stock Analysis Report Idaho Strategic Resources, Inc. (IDR): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: FMC und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf FMC
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf FMC
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Fresenius Medical Care (FMC) St.
Analysen zu Fresenius Medical Care (FMC) St.
Datum | Rating | Analyst | |
---|---|---|---|
21.03.2025 | Fresenius Medical Care (FMC) St Underperform | Jefferies & Company Inc. | |
12.03.2025 | Fresenius Medical Care (FMC) St Buy | Goldman Sachs Group Inc. | |
04.03.2025 | Fresenius Medical Care (FMC) St Underperform | Jefferies & Company Inc. | |
04.03.2025 | Fresenius Medical Care (FMC) St Market-Perform | Bernstein Research | |
27.02.2025 | Fresenius Medical Care (FMC) St Hold | Warburg Research |
Datum | Rating | Analyst | |
---|---|---|---|
12.03.2025 | Fresenius Medical Care (FMC) St Buy | Goldman Sachs Group Inc. | |
27.02.2025 | Fresenius Medical Care (FMC) St Kaufen | DZ BANK | |
25.02.2025 | Fresenius Medical Care (FMC) St Buy | Goldman Sachs Group Inc. | |
30.01.2025 | Fresenius Medical Care (FMC) St Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
28.01.2025 | Fresenius Medical Care (FMC) St Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) |
Datum | Rating | Analyst | |
---|---|---|---|
04.03.2025 | Fresenius Medical Care (FMC) St Market-Perform | Bernstein Research | |
27.02.2025 | Fresenius Medical Care (FMC) St Hold | Warburg Research | |
26.02.2025 | Fresenius Medical Care (FMC) St Hold | Deutsche Bank AG | |
25.02.2025 | Fresenius Medical Care (FMC) St Market-Perform | Bernstein Research | |
25.02.2025 | Fresenius Medical Care (FMC) St Hold | Warburg Research |
Datum | Rating | Analyst | |
---|---|---|---|
21.03.2025 | Fresenius Medical Care (FMC) St Underperform | Jefferies & Company Inc. | |
04.03.2025 | Fresenius Medical Care (FMC) St Underperform | Jefferies & Company Inc. | |
26.02.2025 | Fresenius Medical Care (FMC) St Underweight | JP Morgan Chase & Co. | |
25.02.2025 | Fresenius Medical Care (FMC) St Underperform | Jefferies & Company Inc. | |
25.02.2025 | Fresenius Medical Care (FMC) St Underweight | JP Morgan Chase & Co. |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Fresenius Medical Care (FMC) St. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen